FT Digital Health Summit Europe 2017
- Assess how patients are being empowered and further involved in the transformation of healthcare
- Hear how collaborations between pharma and big tech are enriching the commercial viability of digital health
- Meet and greet with the full array of industry stakeholders, from healthcare to technology, pharma to start-ups, regulation to government
- Identify solutions in overcoming cyber security threats in digital health
- Don’t get left behind - be part of a must-attend event mapping the continued transformation of healthcare
FT Live has a reputation for delivering very senior board level audiences to attend a wide range of world class thought-leadership events across the globe for nearly 40 years.
The FT Digital Health Summit Europe will be attended by:
- Life science companies
- Pharmaceutical and biotechnology companies
- Healthcare providers
- Multi-technology corporations
- Investment banks
- Medical device manufacturers
- Health insurers
- Health/big data companies
- Venture capitalists
- Health regulatory agencies
- Mobile app providers
- Mobile operators and service providers
- Technology consultancies
- Management consultancies
- Telemedicine companies
- Mobile technology manufacturers
- Digital health companies
- Data integrators/analytics/brokers
- Genomics/personalised medicine related companies
- Wireless-device manufacturers
If you book before Thursday 6th April, you will be entitled to a further reduction of £100.
Early Bird Ticket (ends 6 April)
Standard Summit Ticket
AGENDA - 27TH JUN
Registration and welcome reception
Opening remarks from the Chair
David Crow, Senior US Business Correspondent, Financial Times
Panel keynote: Accepting digital health - how much do patients want it?
Juliet Bauer, Director of Digital Experience, NHS England
Accepting digital health: How much do patients want it?
What is the likelihood of providing a digital healthcare system that enables patients of all demographics to use it?
What are the challenges for integrating technology from different providers into one healthcare experience for the patient?
What can be done to increase the use of telemedicine services?
A view from the clinic - are GP telemedicine consultations working?
Juliet Bauer, Director of Digital Experience, NHS England
Chris Day, Director of Engagement, Care Quality Commission
Rachel Dunscombe, Chief Information Officer, Salford Royal NHS Foundation Trust
Robert Johnstone, Patient Advocate and Board Member, European Patients Forum
NHS Digital Keynote
Beverley Bryant, Director of Digital Transformation, NHS Digital
Doctors and Machines: The growing role of advanced technologies in healthcare
What are the main barriers to overcome when trying to move AI in healthcare from the R&D lab to the surgery?
Will advanced machines create even more uncertainty and worry around access to private medical records?
How could technology alter the reimbursement models for healthcare?
Is AI one step too far when asking patients to trust technology in an industry dominated by human interactions?
Adam Hanina, CEO, AiCure
Professor Andrew Price, Professor of Orthopaedic Surgery, University of Oxford
Investing in tech-enabled health now and for a post-Brexit future
Like other markets before it, will digital health investments inevitably reach their peak and slump?
Exploring EU sources of funding: What will happen to them post-Brexit?
Can companies entice investors to come on board with longer term views in mind?
How have the exit strategies changed and are they altering the investor mix?
What would an opening to public markets do for the digital health industry?
What models are showing the best capital returns?
Dr Vishal Gulati, Healthtech Venture Capitalist, Draper Esprit
The economic view - how to monetise the next phase of healthcare's transformation
Which key consumer and patient behavioural patterns are changing the economic landscape for healthcare
Defining the value of digital health by patient activation levels and how, if improved, can they significantly reduce healthcare costs?
Will an economic health model driven more by consumers and patients rather than providers cause significant regulatory problems?
What happens when your innovation is too innovative and worries investors? Is this economically sustainable?
How can NHS England create a single market entry point for new products and services, much like its partners in Scotland and Wales?
Clara Leonard, Associate, Digital Health Ventures
Case study: Healthcare Heroes
Matt Eagles, Patient
David Hunt, Chief Executive, HAVAS LYNX
Disruptor 1 - Dr Talya Miron-Shatz, CEO, CureMyWay and Co-founder, Buddy&Soul
Disruptor 2 - Dr Sukhbinder Noorpuri, Founder and CEO, i-GP
Disruptor 3 - Dr Sai Lakshmi, CEO and Co-founder, Echo
Digital health as a driving force for improving medical adherence
When will mHealth become the norm for tracking patient adherence?
How can digital health technologies be used to improve adherence in clinical trials?
Dr Ralph Abraham, Founder, London Medical
Dr Junaid Bajwa, Executive Director for Healthcare Services, MSD
Mark Duman, Non-Executive Director, Patient Information Forum
The new look for providers - collaborating with a transforming industry
What are the key areas that providers are exploring in the digital health space?
What is joint working in digital health and what evidence is there of this being successful on a mainstream basis?
Who are the partners they most need and are most keen on partnering with?
What role can healthcare partnerships play in making clinical trials more efficient?
How can providers and pharma companies harness data and feedback to better develop products and services in partnership with the NHS?
Dr Sameer Mistry, Medical Director, UK and Ireland, Johnson & Johnson Medical Devices
Irina Osovskaya, Global Director of Mobile and Customer Experience Strategy, AstraZeneca
Plug and play healthcare: An ecosystem accessible for all demographics
How can we overcome a lack of Chief Information and Innovation Officers, who can really drive forward a digital health agenda?
What type of partners are healthcare organisations looking for in order to improve their interoperability?
What impact will the creation of digital academies have?
Analysing the outcomes from the NHS’s Wachter Review
Julie Bretland, Director, Our Mobile Health
Charles Lowe, Managing Director, Digital Health and Care Alliance / Past President - Telemedicine Section, Royal Society of Medicine
Closing remarks from the Chair
Director of Digital Experience
Director of Digital Transformation
Chief Information Officer
Salford Royal NHS Foundation Trust
Our Mobile Health
Dr Karl Pall
Director of Brand Solutions DACH (Germany, Austria and Switzerland)
Mon, 7 Jun 2021 - Wed, 9 Jun 2021
Mon, 7 Jun 2021 - Fri, 11 Jun 2021
Tue, 15 Jun 2021 - Wed, 16 Jun 2021
Sun, 18 Jul 2021 - Thu, 22 Jul 2021
Mon, 20 Sep 2021 - Thu, 23 Sep 2021
Thu, 7 Oct 2021 - Fri, 8 Oct 2021
Mon, 20 Dec 2021 - Wed, 22 Dec 2021